{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:24:31Z","timestamp":1764044671990,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00432-021-03687-3","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T18:02:45Z","timestamp":1623693765000},"page":"2885-2892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1065-2198","authenticated-orcid":false,"given":"M. Constanza","family":"Camargo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkyo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko N.","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kasugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Rabkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2012.00119","volume":"3","author":"JA Araujo","year":"2012","unstructured":"Araujo JA, Zhang M, Yin F (2012) Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol 3:119","journal-title":"Front Pharmacol"},{"issue":"8","key":"3687_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F (2017) Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol 112(8):1247\u20131255","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"3687_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ijc.32763","volume":"147","author":"J Aversa","year":"2020","unstructured":"Aversa J, Song M, Shimazu T, Inoue M, Charvat H, Yamaji T, Sawada N, Pfeiffer RM, Karimi P, Dawsey SM, Rabkin CS, Tsugane S, Camargo MC (2020) Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: a case-cohort study in Japan. Int J Cancer 147(3):686\u2013691","journal-title":"Int J Cancer"},{"issue":"4","key":"3687_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/1055-9965.EPI-18-1157","volume":"28","author":"MC Camargo","year":"2019","unstructured":"Camargo MC, Song M, Shimazu T, Charvat H, Yamaji T, Sawada N, Kemp TJ, Pfeiffer RM, Hildesheim A, Pinto LA, Tsugane S, Rabkin CS (2019) Circulating inflammation markers and risk of gastric and esophageal cancers: a case-cohort study within the japan public health center-based prospective study. Cancer Epidemiol Biomarkers Prev 28(4):829\u2013832","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3687_CR5","first-page":"3649","volume":"20","author":"FF Chen","year":"2019","unstructured":"Chen FF, Zhang SR, Peng H, Chen YZ, Cui XB (2019) Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma. Mol Med Rep 20(4):3649\u20133660","journal-title":"Mol Med Rep"},{"issue":"3","key":"3687_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/jnc.13011","volume":"133","author":"J Chu","year":"2015","unstructured":"Chu J, Li JG, Hoffman NE, Madesh M, Pratico D (2015) Degradation of gamma secretase activating protein by the ubiquitin-proteasome pathway. J Neurochem 133(3):432\u2013439","journal-title":"J Neurochem"},{"issue":"15","key":"3687_CR7","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3748\/wjg.v26.i15.1708","volume":"26","author":"LY Chu","year":"2020","unstructured":"Chu LY, Peng YH, Weng XF, Xie JJ, Xu YW (2020) Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol 26(15):1708\u20131725","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3687_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s13046-019-1498-z","volume":"38","author":"L Han","year":"2019","unstructured":"Han L, Dai S, Li Z, Zhang C, Wei S, Zhao R, Zhang H, Zhao L, Shan B (2019) Combination of the natural compound periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: implication in anticancer therapy. J Exp Clin Cancer Res 38(1):501","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3687_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4149\/neo_2010_01_086","volume":"57","author":"JL Hu","year":"2010","unstructured":"Hu JL, Li ZY, Liu W, Zhang RG, Li GL, Wang T, Ren JH, Wu G (2010) Polymorphism in heme oxygenase-1 (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma 57(1):86\u201392","journal-title":"Neoplasma"},{"issue":"4","key":"3687_CR10","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1074\/jbc.M112.370924","volume":"288","author":"I Hussain","year":"2013","unstructured":"Hussain I, Fabregue J, Anderes L, Ousson S, Borlat F, Eligert V, Berger S, Dimitrov M, Alattia JR, Fraering PC, Beher D (2013) The role of gamma-secretase activating protein (GSAP) and imatinib in the regulation of gamma-secretase activity and amyloid-beta generation. J Biol Chem 288(4):2521\u20132531","journal-title":"J Biol Chem"},{"issue":"9","key":"3687_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/cas.12485","volume":"105","author":"BR Keeley","year":"2014","unstructured":"Keeley BR, Islami F, Pourshams A, Poustchi H, Pak JS, Brennan P, Khademi H, Genden EM, Abnet CC, Dawsey SM, Boffetta P, Malekzadeh R, Sikora AG (2014) Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer. Cancer Sci 105(9):1205\u20131211","journal-title":"Cancer Sci"},{"issue":"9","key":"3687_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/j.1572-0241.2004.30733.x","volume":"99","author":"N Koide","year":"2004","unstructured":"Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S (2004) Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99(9):1667\u20131674","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3687_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2478\/ams-2013-0017","volume":"58","author":"M Kozlowski","year":"2013","unstructured":"Kozlowski M, Laudanski W, Mroczko B, Szmitkowski M, Milewski R, Lapuc G (2013) Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. Adv Med Sci 58(2):227\u2013234","journal-title":"Adv Med Sci"},{"key":"3687_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/978-0-387-89520-8_2","volume":"647","author":"CL Law","year":"2009","unstructured":"Law CL, Grewal IS (2009) Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 647:8\u201336","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"3687_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jjco\/hyp079","volume":"39","author":"P Liu","year":"2009","unstructured":"Liu P, Chen W, Zhu H, Liu B, Song S, Shen W, Wang F, Tucker S, Zhong B, Wang D (2009) Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. Jpn J Clin Oncol 39(10):644\u2013650","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"3687_CR16","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1515\/CCLM.2010.274","volume":"48","author":"M Lukaszewicz-Zajac","year":"2010","unstructured":"Lukaszewicz-Zajac M, Mroczko B, Kozlowski M, Niklinski J, Laudanski J, Szmitkowski M (2010) Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers. Clin Chem Lab Med 48(10):1467\u20131473","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3687_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jso.21921","volume":"104","author":"KJ Luo","year":"2011","unstructured":"Luo KJ, Hu Y, Wen J, Fu JH (2011) CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol 104(3):236\u2013243","journal-title":"J Surg Oncol"},{"issue":"1","key":"3687_CR18","first-page":"171","volume":"19","author":"CCF Luz","year":"2018","unstructured":"Luz CCF, Noguti J, Araujo L, Simao Gomes T, Mara G, Silva MS, Artigiani Neto R (2018) Expression of VEGF and Cox-2 in patients with esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 19(1):171\u2013177","journal-title":"Asian Pac J Cancer Prev"},{"key":"3687_CR19","doi-asserted-by":"publisher","first-page":"35196","DOI":"10.1038\/srep35196","volume":"6","author":"Z Ma","year":"2016","unstructured":"Ma Z, Fan C, Yang Y, Di S, Hu W, Li T, Zhu Y, Han J, Xin Z, Wu G, Zhao J, Li X, Yan X (2016) Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation. Sci Rep 6:35196","journal-title":"Sci Rep"},{"issue":"5","key":"3687_CR20","first-page":"422","volume":"23","author":"T Maruyama","year":"2010","unstructured":"Maruyama T, Kono K, Izawa S, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Fujii H (2010) CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Dis Esophagus 23(5):422\u2013429","journal-title":"Dis Esophagus"},{"key":"3687_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fonc.2017.00051","volume":"7","author":"SG Mathiassen","year":"2017","unstructured":"Mathiassen SG, De Zio D, Cecconi F (2017) Autophagy and the cell cycle: a complex landscape. Front Oncol 7:51","journal-title":"Front Oncol"},{"issue":"9","key":"3687_CR22","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.21873\/anticanres.10991","volume":"36","author":"Y Matsumura","year":"2016","unstructured":"Matsumura Y, Hiraoka K, Ishikawa K, Shoji Y, Noji T, Hontani K, Itoh T, Nakamura T, Tsuchikawa T, Shichinohe T, Hirano S (2016) CD40 Expression in human esophageal squamous cell carcinoma is associated with tumor progression and lymph node metastasis. Anticancer Res 36(9):4467\u20134475","journal-title":"Anticancer Res"},{"issue":"9","key":"3687_CR23","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdx279","volume":"28","author":"G Murphy","year":"2017","unstructured":"Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, Gopal S, Hashemian M, Hu N, Hyland PL, Kaimila B, Kamangar F, Malekzadeh R, Mathew CG, Menya D, Mulima G, Mwachiro MM, Mwasamwaja A, Pritchett N, Qiao YL, Ribeiro-Pinto LF, Ricciardone M, Schuz J, Sitas F, Taylor PR, Van Loon K, Wang SM, Wei WQ, Wild CP, Wu C, Abnet CC, Chanock SJ, Brennan P (2017) International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol 28(9):2086\u20132093","journal-title":"Ann Oncol"},{"issue":"23","key":"3687_CR24","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1091\/mbc.e13-06-0302","volume":"24","author":"H Neto","year":"2013","unstructured":"Neto H, Kaupisch A, Collins LL, Gould GW (2013) Syntaxin 16 is a master recruitment factor for cytokinesis. Mol Biol Cell 24(23):3663\u20133674","journal-title":"Mol Biol Cell"},{"issue":"17","key":"3687_CR25","doi-asserted-by":"publisher","first-page":"6190","DOI":"10.1158\/1078-0432.CCR-04-2553","volume":"11","author":"Y Ren","year":"2005","unstructured":"Ren Y, Cao B, Law S, Xie Y, Lee PY, Cheung L, Chen Y, Huang X, Chan HM, Zhao P, Luk J, Vande Woude G, Wong J (2005a) Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 11(17):6190\u20136197","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3687_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.sla.0000168555.97710.bb","volume":"242","author":"Y Ren","year":"2005","unstructured":"Ren Y, Law S, Huang X, Lee PY, Bacher M, Srivastava G, Wong J (2005b) Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242(1):55\u201363","journal-title":"Ann Surg"},{"issue":"4","key":"3687_CR27","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3892\/or.2016.4556","volume":"35","author":"QG Ren","year":"2016","unstructured":"Ren QG, Yang SL, Hu JL, Li PD, Chen YS, Wang QS (2016) Evaluation of HO-1 expression, cellular ROS production, cellular proliferation and cellular apoptosis in human esophageal squamous cell carcinoma tumors and cell lines. Oncol Rep 35(4):2270\u20132276","journal-title":"Oncol Rep"},{"issue":"12","key":"3687_CR28","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.febslet.2010.03.044","volume":"584","author":"AP Sagona","year":"2010","unstructured":"Sagona AP, Stenmark H (2010) Cytokinesis and cancer. FEBS Lett 584(12):2652\u20132661","journal-title":"FEBS Lett"},{"key":"3687_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","volume":"490","author":"R Saleh","year":"2020","unstructured":"Saleh R, Elkord E (2020) FoxP3(+) T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets. Cancer Lett 490:174\u2013185","journal-title":"Cancer Lett"},{"key":"3687_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3687_CR31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/cells8121655","volume":"8","author":"BL Tang","year":"2019","unstructured":"Tang BL (2019) Syntaxin 16\u2019s newly deciphered roles in autophagy. Cells 8(12):1655","journal-title":"Cells"},{"issue":"5","key":"3687_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1078-0432.CCR-12-2064","volume":"19","author":"RH Vonderheide","year":"2013","unstructured":"Vonderheide RH, Glennie MJ (2013) Agonistic CD40 antibodies and cancer therapy. Clin Cancer Res 19(5):1035\u20131043","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3687_CR33","doi-asserted-by":"publisher","first-page":"107327481987573","DOI":"10.1177\/1073274819875736","volume":"26","author":"B Xie","year":"2019","unstructured":"Xie B, Wang Y, He J, Ni Z, Chai D (2019) Aberrant cyclin E and hepatocyte growth factor expression, microvascular density, and micro-lymphatic vessel density in esophageal squamous cell carcinoma. Cancer Control 26(1):1073274819875736","journal-title":"Cancer Control"},{"issue":"9","key":"3687_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/2211-5463.12228","volume":"7","author":"J Xing","year":"2017","unstructured":"Xing J, Liu C (2017) Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma. FEBS Open Bio 7(9):1246\u20131257","journal-title":"FEBS Open Bio"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03687-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T15:14:34Z","timestamp":1630077274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03687-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03687-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}